Table 3.
Completeness Evaluation by the CHEERS Checklist
| Study | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Item | Afsar AJ, 2001 | Smith AF, 2005 | Maxwell WA, 2008 | Lafuma A, 2008 | Pineda R, 2010 | De Vries NE, 2010 | Lin JC, 2014 | Kristianslund O, 2019 | Hu JQ, 2019 | Simons RWP, 2019 | Bala C, 2022 | Ranno S, 2022 | HQO, 2009 | HTAIn, 2018 |
| Title | ||||||||||||||
| Title | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | N/A | N/A |
| Abstract | ||||||||||||||
| Abstract | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Introduction | ||||||||||||||
| Background and objectives | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Methods | ||||||||||||||
| Health economic analysis plan | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 1 | 1 |
| Study population | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
| Setting and location | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
| Comparators | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Perspective | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 |
| Time horizon | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
| Discount rate | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 |
| Selection of outcomes | N/A | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Measurement of outcomes | N/A | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Valuation of outcomes | N/A | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Measurement and valuation of resources and costs | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Currency, price, date and conversion | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 |
| Rationale and description of model | N/A | N/A | 1 | 1 | 1 | 1 | N/A | N/A | 1 | N/A | 1 | N/A | 1 | N/A |
| Analytics and assumptions | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Characterizing heterogeneity | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 |
| Characterizing distributional effects | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Characterizing uncertainty | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 0 |
| Approach to engagement with patients and others affected by the study | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 1 |
| Results | ||||||||||||||
| Study parameters | N/A | N/A | 1 | 1 | 1 | 1 | N/A | N/A | 1 | N/A | 1 | N/A | 1 | N/A |
| Summary of main results | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Effect of uncertainty | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 0 |
| Effect of engagement with patients and others affected by the study | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 |
| Discussion | ||||||||||||||
| Study findings, limitations, generalizability, and current knowledge | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Other relevant information | ||||||||||||||
| Source of funding | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Conflicts of interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 14 | 23 | 24 | 24 | 25 | 24 | 19 | 24 | 23 | 25 | 25 | 19 | 26 | 22 |
| Percentage (%) | 60.87 | 88.46 | 85.71 | 85.71 | 89.29 | 85.71 | 69.23 | 92.31 | 82.14 | 96.15 | 89.29 | 73.08 | 96.30 | 88.00 |
“0” represents not reported. “1” represents reported. “N/A” represents not applicable.
Percentage (%) = numbers of “1” / (28 - numbers of “N/A”) * 100%.